Next Article in Journal
Non-Coding RNAs in Kidney Stones
Next Article in Special Issue
4-Hydroxy-1α,25-Dihydroxyvitamin D3: Synthesis and Structure–Function Study
Previous Article in Journal
The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann–Pick Disease: A Comprehensive Review
Previous Article in Special Issue
Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
 
 
Article
Peer-Review Record

The Association of Vitamin D Receptor Gene Polymorphisms with Vitamin D, Total IgE, and Blood Eosinophils in Patients with Atopy

Biomolecules 2024, 14(2), 212; https://doi.org/10.3390/biom14020212
by Daina Bastyte 1,2,*, Laura Tamasauskiene 1,2, Ieva Stakaitiene 3, Rasa Ugenskiene 3 and Brigita Gradauskiene (Sitkauskiene) 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Biomolecules 2024, 14(2), 212; https://doi.org/10.3390/biom14020212
Submission received: 15 December 2023 / Revised: 24 January 2024 / Accepted: 9 February 2024 / Published: 11 February 2024

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

The manuscript can be published now.

Author Response

We express our sincere gratitude to the reviewer for dedicating their valuable time to a thorough review of the manuscript.

Reviewer 2 Report

Comments and Suggestions for Authors

This is a cross-sectional case -control study on the associations of VDR polymorphisms with 25(OH)D concentrations in atopic disease compared with controls.

The study lacks a clear research hypothesis:

1) Do specific VDR polymorphisms are associated with atopic outcomes through their effects on 25(OH)D (that means the authors hypothesize that specifix SNPs affect 25-hydroxyvitamin D and results in higher rates of hypovitaminosis D and consequently to aggravation of atopy) -that means you evaluate 25(OH)D in both cases and controls (not just cases as in this study) and elucidate on associations of VDRs SNPs in both groups 

OR

2) VDR polymorphisms are indepedently associated with atopic outcomes (irrespective of 25-OHD) -That means you study vitamin D sufficient populations (both cases and coltrols) and focus on potential associations

Neither of the above has been evaluated in addition to lack of adjustment for seasonal 25(OH)D variation (i.e. would the results be significant in another season ),vitamin D nutritional intake,BMI etc.

Lack of the same analysis for controls as conducted for cases for 25(OH)D and VDRs could reveal similar significant results and largely not apply for atopic patients.I would strongly suggest evaluating VDR and 25 (OH)D tertile associations in controls as well, otherwise the study design is poor.

CVs of assays used as well as other atopic outcomes (inhaler use, hospitalization ) not reported

Comments on the Quality of English Language

Extensive language editing is required

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop